MedPath

Dexamethasone

DEXAMETHASONE Tablets USP, 1.5 mg Rx Only

Approved
Approval ID

fcc75691-974e-4a67-b9d7-64dde72b5595

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 11, 2023

Manufacturers
FDA

Larken Laboratories, Inc.

DUNS: 149484540

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone 1.5 mg

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68047-702
Application NumberANDA201270
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone 1.5 mg
Product Specifications
Route of AdministrationORAL
Effective DateOctober 11, 2023
FDA Product Classification

INGREDIENTS (6)

DEXAMETHASONEActive
Quantity: 1.5 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MALTODEXTRINInactive
Code: 7CVR7L4A2D
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone - FDA Drug Approval Details